Japan approves Pfizer's COVID-19 vaccine for children aged 5-11

Japan's health ministry on Friday approved the administration of Pfizer Inc.'s coronavirus vaccine to children aged between 5 and 11 as the nationwide case count continues to climb with the rapid spread of the Omicron variant.It is the first COVID-19 vaccine made available in Japan for that age group. Inoculations will begin as early as March after specifics, including guidelines, are worked out, according to officials.Up to about 8 million children will be eligible to receive the vaccine, developed by the U.S. pharmaceutical giant and its German partner BioNTech SE, after it was granted sp…READ FULL ARTICLE